Accéder au contenu
Merck

Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature.

The American journal of clinical nutrition (2004-02-27)
Antonius H M Terpstra
RÉSUMÉ

Studies in mice have indicated that feeding diets containing 0.5-1% conjugated linoleic acid (CLA) considerably reduces body fat. These findings have attracted much interest because of the potential use of CLA as a tool to promote weight loss in humans. Several CLA studies in humans have now been published, and the objective of the present review was to give an overview of these experiments. Most of the studies were done in free-living subjects and were not strictly controlled for nutrient and energy intakes. None of the studies found a significant reduction in body weight, and only 2 studies showed a significant but relatively small body fat-lowering effect. Some studies suggested that CLA may have a tendency to increase lean body mass. Furthermore, there are indications from animal studies that CLA may have effects on plasma lipids. However, only one study in humans showed a significant HDL-cholesterol-lowering effect of CLA; in all the other studies, there were no significant effects on plasma total, LDL-, and HDL-cholesterol concentrations or on plasma triacylglycerol concentrations. Thus, the results of the studies in humans indicate that the effect of CLA on body fat is considerably less than that anticipated from mice studies and that CLA has no major effect on plasma lipids.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acide linoléique, ≥99%
Sigma-Aldrich
Acide linoléique, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Acide linoléique, technical, 58-74% (GC)
Supelco
Acide linoléique, analytical standard